Chemotherapy-induced neutropenic necrotizing enterocolitis: a review

• Published in: Journal of the Pakistan Medical Association 2012-07, Vol.62 (7), p.718-723
• Main Authors: Mehdi, Itrat, Al Bahrani, Bassim
• Format: Article
• Language: English
• Subjects: Antineoplastic Agents - adverse effects; Cancer; Care and treatment; Chemotherapy; Diagnosis; Diagnostic Imaging; Enterocolitis; Enterocolitis, Necrotizing - chemically induced; Enterocolitis, Necrotizing - diagnosis; Enterocolitis, Neutropenic - chemically induced; Enterocolitis, Neutropenic - diagnosis; Health aspects; Humans; Risk factors
• ISSN: 0030-9982

Neutropenia is a common toxicity of systemic cytotoxic therapy. Neutropenic enterocolitis (NE) is a rare occurrence but can be fatal, subsequent to neutropenia. The exact incidence and frequency is difficult to establish, but is usually underestimated. It is often missed but has recently been appreciated with increasing frequency in solid tumours. NE was initially reported with taxenes but now an increasing number of chemotherapeutic drugs are implicated. NE incidence is expected to increase with the use of dose dense regimens, myeloablative cytotoxic protocols, tissue transplants, and emerging newer molecules. The usual presentation is often non-specific and often over shadowed by the symptomatology of primary malignant disease and toxicity symptoms of chemotherapy. The basis of diagnosis is clinical, radiological (ultra sound/CT scan), per operative findings, and eventually post mortem. Treatment options of this highly fatal phenomenon varies from conservative to early surgical intervention. NE is expected to be diagnosed with increasing frequency. The factors leading to it are mucosal injury, caecal distension with resultant ischaemia, cytotoxic drugs, and microbiological agents. A high index of clinical suspicion and an early diagnosis is paramount for better outcome. Irrespective of management employed, conservative or upfront surgical intervention, it has a poor out come with high mortality. A clinical suspicion, early diagnosis, and prompt management are the key to a better result. There is need to identify people at high risk by prognostic factors, large scale studies, and formulating consensus management guidelines. At present individualized risk assessment based strategy is advocated.